June 2026

Viloxazine Extended Release in Adults With Attention-Deficit/Hyperactivity Disorder and Depression and/or Anxiety Symptoms: Results From a Decentralized, Open-Label, Phase 4 Trial

A major new study for families with ADHD has been published in the Journal of Clinical Psychiatry. This article examines the complex comorbidities and the unique challenges presented by our patients in clinical practice. This study enrolled not only adults with ADHD but also those experiencing concurrent anxiety, depression, insomnia, and/or cannabis use. The findings demonstrate real-world improvements in mood, anxiety, and sleep when ADHD is better managed.

Did You Know?

We record our webinars for you to view at your convenience!

The APSARD Webinar series was launched to provide ongoing professional education activities that further our mission of improving the quality of care for patients with ADHD through the advancement and dissemination of research and evidence-based practices.

Our webinars are FREE to members AND nonmembers alike!

Stay tuned for future 2026 webinars!!

Did You Miss A Newsletter?

APSARD News & Updates not only contains content that addresses mental health for practitioners, children and adults, ADHD and related disorders, but also overall society updates, including important conference information, upcoming deadlines, & membership benefits.

Don't miss out on catching up today!